Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017 (2017), Article ID 1026270, 11 pages
https://doi.org/10.1155/2017/1026270
Review Article

Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes

1Clinical Research Institute, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
2Key Laboratory of Cancer Molecular Diagnosis and Individualized Therapy of Zhejiang Province, Hangzhou 310014, China
3Department of Gastrointestinal Surgery, Shaoxing People’s Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing 312000, China
4School of Basic Medical Sciences, Hangzhou Medical College, Hangzhou 310053, China

Correspondence should be addressed to Xiao-Zhou Mou; nc.ude.ujz@zxuom

Received 31 March 2017; Accepted 16 May 2017; Published 19 June 2017

Academic Editor: Kai Yang

Copyright © 2017 Ying-Yu Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Stegh, “Toward personalized cancer nanomedicine—past, present, and future,” Integrative biology: Quantitative Biosciences from Nano to Macro, vol. 5, no. 1, pp. 48–65, 2013. View at Publisher · View at Google Scholar
  2. R. Etzioni, N. Urban, S. Ramsey et al., “The case for early detection,” Nature Reviews Cancer, vol. 3, no. 4, pp. 243–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Weissleder and M. J. Pittet, “Imaging in the era of molecular oncology,” Nature, vol. 452, no. 7187, pp. 580–589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Davis, Z. G. Chen, and D. M. Shin, “Nanoparticle therapeutics: an emerging treatment modality for cancer,” Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 771–782, 2008. View at Google Scholar · View at Scopus
  5. R. Li, X. Li, L. Xie et al., “Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery,” International Journal of Pharmaceutics, vol. 379, no. 1, pp. 158–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Li, W. Wu, Q. Liu et al., “Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles,” PLoS ONE, vol. 8, no. 7, Article ID e69643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Li, L. Xie, Z. Zhu et al., “Reversion of pH-induced physiological drug resistance: A novel function of copolymeric nanoparticles,” PLoS ONE, vol. 6, no. 9, Article ID e24172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. P. U. Atukorale, G. Covarrubias, L. Bauer, and E. Karathanasis, “Vascular targeting of nanoparticles for molecular imaging of diseased endothelium,” Advanced Drug Delivery Reviews, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. D.-E. Lee, H. Koo, I.-C. Sun, J. H. Ryu, K. Kim, and I. C. Kwon, “Multifunctional nanoparticles for multimodal imaging and theragnosis,” Chemical Society Reviews, vol. 41, no. 7, pp. 2656–2672, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Chen, K. Ai, J. Liu, X. Ren, C. Jiang, and L. Lu, “Polydopamine-based coordination nanocomplex for T1/T2 dual mode magnetic resonance imaging-guided chemo-photothermal synergistic therapy,” Biomaterials, vol. 77, pp. 198–206, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Estelrich, M. J. Sánchez-Martín, and M. A. Busquets, “Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents,” International Journal of Nanomedicine, vol. 10, pp. 1727–1741, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wei, R. Liao, H. Liu, H. Li, H. Xu, and Q. Zhou, “Biocompatible low-retention superparamagnetic iron oxide nanoclusters as contrast agents for magnetic resonance imaging of liver tumor,” Journal of Biomedical Nanotechnology, vol. 11, no. 5, pp. 854–864, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. F. A. Jaffer and R. Weissleder, “Molecular imaging in the clinical arena,” Journal of the American Medical Association, vol. 293, no. 7, pp. 855–862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. McCarthy and R. Weissleder, “Multifunctional magnetic nanoparticles for targeted imaging and therapy,” Advanced Drug Delivery Reviews, vol. 60, no. 11, pp. 1241–1251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Weissleder, “Molecular imaging in cancer,” Science, vol. 312, no. 5777, pp. 1168–1171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. K. Jain and T. Stylianopoulos, “Delivering nanomedicine to solid tumors,” Nature Reviews Clinical Oncology, vol. 7, no. 11, pp. 653–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Petros and J. M. DeSimone, “Strategies in the design of nanoparticles for therapeutic applications,” Nature Reviews Drug Discovery, vol. 9, no. 8, pp. 615–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. E. Hansen, A. L. Petersen, J. R. Henriksen et al., “Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes,” ACS Nano, vol. 9, no. 7, pp. 6985–6995, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Sykes, J. Chen, G. Zheng, and W. C. W. Chan, “Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency,” ACS Nano, vol. 8, no. 6, pp. 5696–5706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. C. Gad, K. L. Sharp, C. Montgomery, J. D. Payne, and G. P. Goodrich, “Evaluation of the toxicity of intravenous delivery of auroshell particles (Gold-Silica Nanoshells),” International Journal of Toxicology, vol. 31, no. 6, pp. 584–594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Key and J. F. Leary, “Nanoparticles for multimodal in vivo imaging in nanomedicine,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 711–726, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Heidari Majd, D. Asgari, J. Barar et al., “Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer,” Colloids and Surfaces B: Biointerfaces, vol. 106, pp. 117–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Lin, Y. Li, Y. Li et al., “Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging,” ACS Applied Materials and Interfaces, vol. 7, no. 22, pp. 11908–11920, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Omidi and J. Barar, “Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures,” International Journal of Toxicology, vol. 28, no. 2, pp. 113–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. B. Hartono, W. Gu, F. Kleitz et al., “Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery,” ACS Nano, vol. 6, no. 3, pp. 2104–2117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Tohidkia, J. Barar, F. Asadi, and Y. Omidi, “Molecular considerations for development of phage antibody libraries,” Journal of Drug Targeting, vol. 20, no. 3, pp. 195–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Zhang, Y.-C. Chiu, L. H. Tostanoski, and C. M. Jewell, “Polyelectrolyte multilayers assembled entirely from immune signals on gold nanoparticle templates promote antigen-specific T cell response,” ACS Nano, vol. 9, no. 6, pp. 6465–6477, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Zhao, M. R. Tohidkia, D. L. Siegel, G. Coukos, and Y. Omidi, “Phage antibody display libraries: A powerful antibody discovery platform for immunotherapy,” Critical Reviews in Biotechnology, vol. 36, no. 2, pp. 276–289, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. H. Lao, K. K. L. Phua, and K. W. Leong, “Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation,” ACS Nano, vol. 9, no. 3, pp. 2235–2254, 2015. View at Publisher · View at Google Scholar
  30. H. Sun and Y. Zu, “Aptamers and their applications in nanomedicine,” Small, vol. 11, no. 20, pp. 2352–2364, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Zhang, X. Huang, L. Zhu et al., “Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles,” Biomaterials, vol. 33, no. 21, pp. 5414–5422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. de Vries, E. Custers, J. Lub, S. van den Bosch, K. Nicolay, and H. Grüll, “Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents,” Biomaterials, vol. 31, no. 25, pp. 6537–6544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Hyafil, J.-C. Cornily, J. E. Feig et al., “Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography,” Nature Medicine, vol. 13, no. 5, pp. 636–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. W. H. Kong, W. J. Lee, Z. Y. Cui et al., “Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging,” Biomaterials, vol. 28, no. 36, pp. 5555–5561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. B. Elrod, R. Partha, D. Danila, S. W. Casscells, and J. L. Conyers, “An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 5, no. 1, pp. 42–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Skajaa, D. P. Cormode, E. Falk, W. J. M. Mulder, E. A. Fisher, and Z. A. Fayad, “High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Aviv, S. Bartling, F. Kieslling, and S. Margel, “Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications,” Biomaterials, vol. 30, no. 29, pp. 5610–5616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Galperin, D. Margel, J. Baniel, G. Dank, H. Biton, and S. Margel, “Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications,” Biomaterials, vol. 28, no. 30, pp. 4461–4468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Zheng, N. Muhanna, R. De Souza et al., “A multimodal nano agent for image-guided cancer surgery,” Biomaterials, vol. 67, pp. 160–168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Zheng, C. Allen, S. Serra, D. Vines, M. Charron, and D. A. Jaffray, “Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: Validation with FDG-PET and histology,” Contrast Media and Molecular Imaging, vol. 5, no. 3, pp. 147–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Zheng, D. Jaffray, and C. Allen, “Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model,” Molecular Pharmaceutics, vol. 6, no. 2, pp. 571–580, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Patel, T. Kato, H. Ujiie et al., “Multi-modal imaging in a mouse model of orthotopic lung cancer,” PLoS ONE, vol. 11, no. 9, Article ID e0161991, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Nakagawa, K. Gonda, T. Kamei et al., “X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface,” Science and Technology of Advanced Materials, vol. 17, no. 1, pp. 387–397, 2016. View at Publisher · View at Google Scholar
  44. X. Chen, H. Zhu, X. Huang et al., “Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancer,” Nanoscale, vol. 9, no. 6, pp. 2219–2231, 2017. View at Publisher · View at Google Scholar
  45. W. Hou, F. Xia, G. Alfranca et al., “Nanoparticles for multi-modality cancer diagnosis: simple protocol for self-assembly of gold nanoclusters mediated by gadolinium ions,” Biomaterials, vol. 120, pp. 103–114, 2017. View at Publisher · View at Google Scholar
  46. Z. Zhou, C. Zhang, Q. Qian et al., “Folic acid-conjugated silica capped gold nanoclusters for targeted fluorescence/X-ray computed tomography imaging,” Journal of Nanobiotechnology, vol. 11, article 17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Cheng, J. Liu, X. Gu et al., “PEGylated WS2 nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy,” Advanced Materials, vol. 26, no. 12, pp. 1886–1893, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Yong, L. Zhou, Z. Gu et al., “WS2 nanosheet as a new photosensitizer carrier for combined photodynamic and photothermal therapy of cancer cells,” Nanoscale, vol. 6, no. 17, pp. 10394–10403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Zhou, B. Kong, C. Yu et al., “Tungsten oxide nanorods: an efficient nanoplatform for tumor CT imaging and photothermal therapy,” Scientific Reports, vol. 4, article 3653, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Tian, X. Zhang, X. Zheng et al., “Multifunctional Rbx WO3 nanorods for simultaneous combined chemo-photothermal therapy and photoacoustic/CT imaging,” Small, vol. 10, no. 20, pp. 4160–4170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Aime, C. Cabella, S. Colombatto, S. G. Crich, E. Gianolio, and F. Maggioni, “Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations,” Journal of Magnetic Resonance Imaging: JMRI, vol. 16, no. 4, pp. 394–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. W.-F. Liu, S.-R. Ji, J.-J. Sun et al., “CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancer,” International Journal of Molecular Sciences, vol. 13, no. 5, pp. 6399–6406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov, and T. J. Brady, “Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties,” Magnetic Resonance in Medicine, vol. 29, no. 5, pp. 599–604, 1993. View at Publisher · View at Google Scholar · View at Scopus
  54. M. G. Harisinghani, J. Barentsz, P. F. Hahn et al., “Noninvasive detection of clinically occult lymph-node metastases in prostate cancer,” The New England Journal of Medicine, vol. 348, no. 25, pp. 2491–2499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Weissleder, D. D. Stark, B. L. Engelstad et al., “Superparamagnetic iron oxide: pharmacokinetics and toxicity,” American Journal of Roentgenology, vol. 152, no. 1, pp. 167–173, 1989. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Josephson, C.-H. Tung, A. Moore, and R. Weissleder, “High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates,” Bioconjugate Chemistry, vol. 10, no. 2, pp. 186–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Wunderbaldinger, L. Josephson, and R. Weissleder, “Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents,” Academic Radiology, vol. 9, Supplement 2, no. 2, pp. S304–S306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. A. R. Guimaraes, E. Rakhlin, R. Weissleder, and S. P. Thayer, “Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model,” Pancreas, vol. 37, no. 4, pp. 440–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Harisinghani, R. W. Ross, A. R. Guimaraes, and R. Weissleder, “Utility of a new bolus-injectable nanoparticle for clinical cancer staging,” Neoplasia, vol. 9, no. 12, pp. 1160–1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. K. A. Kelly, N. Bardeesy, R. Anbazhagan et al., “Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma,” PLoS Medicine, vol. 5, no. 4, article e85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Montet, R. Weissleder, and L. Josephson, “Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas,” Bioconjugate Chemistry, vol. 17, no. 4, pp. 905–911, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Weissleder, G. Elizondo, J. Wittenberg, C. A. Rabito, H. H. Bengele, and L. Josephson, “Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging,” Radiology, vol. 175, no. 2, pp. 489–493, 1990. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Li, S. Tutton, A. T. Vu et al., “First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent,” Journal of Magnetic Resonance Imaging: JMRI, vol. 21, no. 1, pp. 46–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Bremer, M. Mustafa, A. Bogdanov Jr., V. Ntziachristos, A. Petrovsky, and R. Weissleder, “Steady-state blood volume measurements in experimental tumors with different angiogenic burdens—a study in mice,” Radiology, vol. 226, no. 1, pp. 214–220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Tang, M. Kim, D. Carrasco, A. L. Kung, L. Chin, and R. Weissleder, “In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging,” Cancer Research, vol. 65, no. 18, pp. 8324–8330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. J. P. Morton, M. E. Mongeau, D. S. Klimstra et al., “Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5103–5108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Wang, J. Ruan, Q. Qian et al., “BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer,” Journal of Nanobiotechnology, vol. 9, article no. 23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Tatsumi, N. Tanigawa, H. Nishimura et al., “Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10,” Gastric Cancer, vol. 9, no. 2, pp. 120–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Deshpande, M. A. Pysz, and J. K. Willmann, “Molecular ultrasound assessment of tumor angiogenesis,” Angiogenesis, vol. 13, no. 2, pp. 175–188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Hwang, A. Lyshchik, and A. C. Fleischer, “Molecular sonography with targeted microbubbles: Current investigations and potential applications,” Ultrasound Quarterly, vol. 26, no. 2, pp. 75–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Kiessling, J. Huppert, and M. Palmowski, “Functional and molecular ultrasound imaging: Concepts and contrast agents,” Current Medicinal Chemistry, vol. 16, no. 5, pp. 627–642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. W. T. Phillips, A. Bao, A. J. Brenner, and B. A. Goins, “Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles,” Advanced Drug Delivery Reviews, vol. 76, no. 1, pp. 39–59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. S. R. Sirsi and M. A. Borden, “State-of-the-art materials for ultrasound-triggered drug delivery,” Advanced Drug Delivery Reviews, vol. 72, pp. 3–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Rizzitelli, P. Giustetto, J. C. Cutrin et al., “Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound,” Journal of Controlled Release, vol. 202, pp. 21–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. J. J. Rychak and A. L. Klibanov, “Nucleic acid delivery with microbubbles and ultrasound,” Advanced Drug Delivery Reviews, vol. 72, pp. 82–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Kiessling, S. Fokong, J. Bzyl, W. Lederle, M. Palmowski, and T. Lammers, “Recent advances in molecular, multimodal and theranostic ultrasound imaging,” Advanced Drug Delivery Reviews, vol. 72, pp. 15–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Gao, D. Wen, and G. B. Sukhorukov, “Composite silica nanoparticle/polyelectrolyte microcapsules with reduced permeability and enhanced ultrasound sensitivity,” Journal of Materials Chemistry B, vol. 3, no. 9, pp. 1888–1897, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Chen, S. Ratnayaka, A. Alford et al., “Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery,” ACS Nano, vol. 11, no. 3, pp. 3135–3146, 2017. View at Publisher · View at Google Scholar
  79. N. Deshpande, Y. Ren, K. Foygel, J. Rosenberg, and J. K. Willmann, “Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging,” Radiology, vol. 258, no. 3, pp. 804–811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. J. K. Willmann, R. Paulmurugan, K. Chen et al., “US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice,” Radiology, vol. 246, no. 2, pp. 508–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. F.-Y. Yang, T.-T. Wong, M.-C. Teng et al., “Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme,” Journal of Controlled Release, vol. 160, no. 3, pp. 652–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. O. D. Kripfgans, J. B. Fowlkes, D. L. Miller, O. P. Eldevik, and P. L. Carson, “Acoustic droplet vaporization for therapeutic and diagnostic applications,” Ultrasound in Medicine and Biology, vol. 26, no. 7, pp. 1177–1189, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. K. W. Ferrara, “Driving delivery vehicles with ultrasound,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1097–1102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Huang, J. S. Xu, and R. X. Xu, “Heat-sensitive microbubbles for intraoperative assessment of cancer ablation margins,” Biomaterials, vol. 31, no. 6, pp. 1278–1286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Zhang, M. L. Fabiilli, K. J. Haworth et al., “Initial investigation of acoustic droplet vaporization for occlusion in canine kidney,” Ultrasound in Medicine and Biology, vol. 36, no. 10, pp. 1691–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Rapoport, Z. Gao, and A. Kennedy, “Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy,” Journal of the National Cancer Institute, vol. 99, no. 14, pp. 1095–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. N. Y. Rapoport, A. L. Efros, D. A. Christensen, A. M. Kennedy, and K.-H. Nam, “Microbubble generation in phase-shift nanoemulsions used as anticancer drug carriers,” Bubble Science, Engineering and Technology, vol. 1, no. 1-2, pp. 31–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. C.-H. Wang, S.-T. Kang, Y.-H. Lee, Y.-L. Luo, Y.-F. Huang, and C.-K. Yeh, “Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis,” Biomaterials, vol. 33, no. 6, pp. 1939–1947, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. M. L. Fabiilli, K. J. Haworth, N. H. Fakhri, O. D. Kripfgans, P. L. Carson, and J. B. Fowlkes, “The role of inertial cavitation in acoustic droplet vaporization,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 56, no. 5, pp. 1006–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. N. Reznik, M. Seo, R. Williams et al., “Optical studies of vaporization and stability of fluorescently labelled perfluorocarbon droplets,” Physics in Medicine and Biology, vol. 57, no. 21, pp. 7205–7217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. S. R. Sirsi, C. Fung, S. Garg, M. Y. Tianning, P. A. Mountford, and M. A. Borden, “Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery,” Theranostics, vol. 3, no. 6, pp. 409–419, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Singh, G. A. Husseini, and W. G. Pitt, “Phase transitions of nanoemulsions using ultrasound: experimental observations,” Ultrasonics Sonochemistry, vol. 19, no. 5, pp. 1120–1125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Baghbani, M. Chegeni, F. Moztarzadeh, S. Hadian-Ghazvini, and M. Raz, “Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: curcumin,” Materials science & engineering C, Materials for biological applications, vol. 74, pp. 186–193, 2017. View at Google Scholar
  94. J. Li, Y. Tian, D. Shan et al., “Neuropeptide Y Y1 receptor-mediated biodegradable photoluminescent nanobubbles as ultrasound contrast agents for targeted breast cancer imaging,” Biomaterials, vol. 116, pp. 106–117, 2017. View at Publisher · View at Google Scholar
  95. J. Ma, M. Shen, C. S. Xu, Y. Sun, Y. R. Duan, and L. F. Du, “Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro,” Oncotarget, vol. 7, no. 48, pp. 80008–80018, 2016. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Basu and A. Alavi, “PET-Based Personalized Management in Clinical Oncology: an Unavoidable Path for the Foreseeable Future,” PET Clinics, vol. 11, no. 3, pp. 203–207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. D. A. Torigian, A. Kjær, H. Zaidi, and A. Alavi, “PET/MR imaging: clinical applications,” PET Clinics, vol. 11, no. 4, pp. xi–xii, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Zhou, R. Zhang, M. Huang et al., “A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy,” Journal of the American Chemical Society, vol. 132, no. 43, pp. 15351–15358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Aghanejad, A. R. Jalilian, K. Ardaneh, F. Bolourinovin, H. Yousefnia, and A. B. Samani, “Preparation and Quality Control of 68Ga-Citrate for PET Applications,” Asia Oceania Journal of Nuclear Medicine and Biology, vol. 3, no. 2, pp. 99–106, 2015. View at Google Scholar
  100. D. Zeng, N. S. Lee, Y. Liu et al., “64Cu core-labeled nanoparticles with high specific activity via metal-free click chemistry,” ACS Nano, vol. 6, no. 6, pp. 5209–5219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Wong, L. Li, J. Chea et al., “PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs,” Nuclear Medicine and Biology, vol. 47, pp. 62–68, 2017. View at Publisher · View at Google Scholar
  102. Y. Xiao, H. Hong, V. Z. Matson et al., “Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging,” Theranostics, vol. 2, no. 8, pp. 757–768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. S. S. Gambhir, “Molecular imaging of cancer with positron emission tomography,” Nature Reviews Cancer, vol. 2, no. 9, pp. 683–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. G. J. Kelloff, J. M. Hoffman, B. Johnson et al., “Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development,” Clinical Cancer Research, vol. 11, no. 8, pp. 2785–2808, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. J. T. Jørgensen, K. Norregaard, P. Tian, P. M. Bendix, A. Kjaer, and L. B. Oddershede, “Single Particle and PET-based Platform for Identifying Optimal Plasmonic Nano-Heaters for Photothermal Cancer Therapy,” Scientific Reports, vol. 6, Article ID 30076, 2016. View at Publisher · View at Google Scholar · View at Scopus
  106. H. Hong, F. Chen, Y. Zhang, and W. Cai, “New radiotracers for imaging of vascular targets in angiogenesis-related diseases,” Advanced Drug Delivery Reviews, vol. 76, no. 1, pp. 2–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Ferlin, M. Pengo, R. Selice, L. Salmaso, A. Garolla, and C. Foresta, “Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility,” Endocrine-Related Cancer, vol. 15, no. 2, pp. 429–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Radu, C. Pichon, P. Camparo et al., “Expression of follicle-stimulating hormone receptor in tumor blood vessels,” The New England Journal of Medicine, vol. 363, no. 17, pp. 1621–1630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Siraj, V. Desestret, M. Antoine et al., “Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases,” BMC Cancer, vol. 13, article 246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Xu, D. Pan, C. Zhu et al., “Pilot study of a novel 18F-labeled FSHR probe for tumor imaging,” Molecular Imaging and Biology, vol. 16, no. 4, pp. 578–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. H. Hong, Y. Yan, S. Shi et al., “PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging,” Molecular Pharmaceutics, vol. 12, no. 2, pp. 403–410, 2015. View at Publisher · View at Google Scholar · View at Scopus
  112. X.-Y. Zhang, J. Chen, Y.-F. Zheng et al., “Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo,” Cancer Research, vol. 69, no. 16, pp. 6506–6514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. D. A. Modi, S. Sunoqrot, J. Bugno, D. D. Lantvit, S. Hong, and J. E. Burdette, “Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells,” Nanoscale, vol. 6, no. 5, pp. 2812–2820, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. D. Yang, L. Feng, C. A. Dougherty et al., “In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide,” Biomaterials, vol. 104, pp. 361–371, 2016. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Key, C. Cooper, A. Y. Kim et al., “In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles,” Journal of Controlled Release, vol. 163, no. 2, pp. 249–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Aryal, J. Key, C. Stigliano, M. D. Landis, D. Y. Lee, and P. Decuzzi, “Positron emitting magnetic nanoconstructs for PET/MR imaging,” Small, vol. 10, no. 13, pp. 2688–2696, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. I.-C. Sun, D.-K. Eun, H. Koo et al., “Tumor-targeting gold particles for dual computed tomography/optical cancer imaging,” Angewandte Chemie - International Edition, vol. 50, no. 40, pp. 9348–9351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. G. Wang, W. Gao, X. Zhang, and X. Mei, “Au Nanocage Functionalized with Ultra-small Fe3O4 Nanoparticles for Targeting T1-T2 Dual MRI and CT Imaging of Tumor,” Scientific Reports, vol. 6, Article ID 28258, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Key and K. Park, “Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy,” International Journal of Molecular Sciences, vol. 18, no. 3, p. 594, 2017. View at Publisher · View at Google Scholar
  120. K.-H. Lee, E. Liapi, J. A. Vossen et al., “Distribution of iron oxide-containing embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy,” Journal of Vascular and Interventional Radiology, vol. 19, no. 10, pp. 1490–1496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. D.-H. Kim, W. Li, J. Chen et al., “Multimodal imaging of nanocomposite microspheres for transcatheter intra-arterial drug delivery to liver tumors,” Scientific Reports, vol. 6, Article ID 29653, 2016. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Tian, Z. Xie, M. L. Fabiilli, and X. Wang, “Imaging and sensing based on dual-pulse nonlinear photoacoustic contrast: a preliminary study on fatty liver,” Optics Letters, vol. 40, no. 10, pp. 2253–2256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  123. L. V. Wang and S. Hu, “Photoacoustic tomography: in vivo imaging from organelles to organs,” Science, vol. 335, no. 6075, pp. 1458–1462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. R. Alwi, S. Telenkov, A. Mandelis et al., “Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics,” Biomedical Optics Express, vol. 3, no. 10, pp. 2500–2509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. X. Yang, S. E. Skrabalak, Z.-Y. Li, Y. Xia, and L. V. Wang, “Photoacoustic tomography of a rat cerebral cortex in vivo with Au nanocages as an optical contrast agent,” Nano Letters, vol. 7, no. 12, pp. 3798–3802, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. E. C. Dreaden, A. M. Alkilany, X. Huang, C. J. Murphy, and M. A. El-Sayed, “The golden age: gold nanoparticles for biomedicine,” Chemical Society Reviews, vol. 41, no. 7, pp. 2740–2779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. W. He, K. Ai, C. Jiang, Y. Li, X. Song, and L. Lu, “Plasmonic titanium nitride nanoparticles for in vivo photoacoustic tomography imaging and photothermal cancer therapy,” Biomaterials, vol. 132, pp. 37–47, 2017. View at Publisher · View at Google Scholar
  128. J. T. Douglas, M. Kim, L. A. Sumerel, D. E. Carey, and D. T. Curiel, “Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary Ad receptors,” Cancer Research, vol. 61, no. 3, pp. 813–817, 2001. View at Google Scholar · View at Scopus
  129. H. Mizuguchi and T. Hayakawa, “Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase,” Cancer Gene Therapy, vol. 9, no. 3, pp. 236–242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. F. Scherer, M. Anton, and U. Schillinger, “Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo,” Gene Therapy, vol. 9, no. 2, pp. 102–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. J.-W. Choi, J.-S. Lee, S. W. Kim, and C.-O. Yun, “Evolution of oncolytic adenovirus for cancer treatment,” Advanced Drug Delivery Reviews, vol. 64, no. 8, pp. 720–729, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. J.-W. Choi, J. W. Park, Y. Na et al., “Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy,” Biomaterials, vol. 65, pp. 163–174, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. J. Chen, P. Gao, S. Yuan et al., “Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy,” ACS Nano, vol. 10, no. 12, pp. 11548–11560, 2016. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Goel, S. K. Carlson, K. L. Classic et al., “Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene,” Blood, vol. 110, no. 7, pp. 2342–2350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Pañeda, M. Collantes, S. G. Beattie et al., “Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primates,” Human Gene Therapy, vol. 22, no. 8, pp. 999–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus